Emerging Advances in FFR-CT for Cardiac Care

The Society of Cardiovascular Computed Tomography (SCCT) recently issued an expert consensus document advocating for standardization in coronary CT angiography-derived fractional flow reserve (FFR-CT) technology, highlighting its potential to revolutionize cardiac care. This document underscores emerging areas where FFR-CT can be expanded and integrated into clinical practice.

Significant advancements in the field include the incorporation of additional hemodynamic parameters, such as wall shear stress and axial plaque stress. Researchers posit that these enhancements could significantly enhance the predictive capabilities of FFR-CT for myocardial infarction, all while avoiding the need for additional segmentation or computational costs.

The SCCT document refers to the EMERALD and EMERALD II studies, which investigated plaque rupture mechanisms in acute coronary syndrome (ACS) using FFR-CT. These studies revealed that including wall shear stress and axial plaque stress greatly improved the accuracy of FFR-CT in forecasting future heart attacks. "The risk of ACS does not solely rely on the forces within the lumen but also on the plaque composition," the authors noted, emphasizing this finding's importance.

In clinical practice, some interventional cardiology departments are already applying CCTA imaging combined with FFR-CT to enhance planning for percutaneous coronary interventions (PCI). The integration of this technology reduces procedural surprises and enables precise preemptive revascularization decisions. Initial studies suggest that simulated stent deployment using digital anatomical models and FFR-CT can further refine PCI planning by estimating the impacts of various stenting strategies.

Photon counting CT (PCCT) systems are also anticipated to play a pivotal role in improving FFR-CT's accuracy. Current CT systems face spatial resolution limitations due to the detectors used, but PCCT detectors present an opportunity to improve coronary delineation and stenosis assessment. These systems offer a spectral imaging component that aids in element-specific image refinement, such as reducing calcification artifacts.

"Photon counting CT systems feature detectors that are markedly more efficient than conventional ones," explained Ronen Rubinshtein, MD, a leading cardiologist and SCCT's upcoming president. Early studies illustrate promising agreement between CT-FFR derived from photon counting detectors and traditional invasive FFR measurements, with prospective studies planned to explore this correlation further.

Manufacturers like Siemens and GE Healthcare have already introduced FDA-cleared photon-counting CT systems, with Canon Medical also showcasing its prototype. As this technology evolves, it is poised to become integral to advanced cardiac imaging, transforming the landscape of CT system capabilities.

SCCT's concerted efforts to advance FFR-CT technology align with broader trends in radiology and cardiology, reflecting a commitment to improving patient outcomes through innovation and standardization.